Astellas Offers $3.5 Billion For OSI Pharmaceuticals

Japan's second largest drugmaker Astellas made an unsolicited $3.5 billion hostile bid for OSI Pharmaceuticals Inc. (Nasdaq: OSIP) sending the stock price soaring $19.46 to $56.48.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.